Serum Institute's 2nd Covid vaccine likely to be launched in September

Gallery

MORE...

Sports

Satwik-Chirag return as BAI names 14-strong squad for BWF Sudirman Cup Finals 2025

The Badminton Association of India (BAI) has announced a 14-member-strong India squad for

Men’s Sr Hockey Nationals to be played in division-based format from April 4

Mensik denies Djokovic 100th title in Miami final

KIPG: Son of a vegetable vendor, Bihar’s Jhandu Kumar eyes Worlds, 2028 Paralympics

Hardik Singh credits hard work and team unity for receiving HI Midfielder of the Year award

Djokovic, Alcaraz land in same half of Miami draw

MORE...

Serum Institute's 2nd Covid vaccine likely to be launched in September

Last Updated : 27 Mar 2021 03:18:58 PM IST

Serum Institute CEO Adar Poonawalla

Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax by September this year, CEO Adar Poonawalla announced on Saturday.

"Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India," said Adar Poonawalla.

He further said that it has been tested against African and UK variants of Covid-19 and has an overall efficacy of 89 per cent. "Hope to launch by September 2021!" the CEO of world's biggest Covid-19 vaccine maker said.

Covovax is the protein-based Covid-19 vaccine developed by Novavax, headquartered in the US.

In August 2020, the two companies announced an agreement under which Novavax had given SII the licence to manufacture and supply the vaccine in low- and middle-income countries.